Edding Genor Group Holdings (HKSE:06998) PS Ratio: (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06998 Edding Genor Group Holdings Ltd HKSE:06998
15 GF Score
Price HK$1.69
! 1 Warning Sign
View Full Analysis

What is Edding Genor Group Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Edding Genor Group Holdings's share price is HK$1.69. Edding Genor Group Holdings does not have enough years/quarters to calculate the Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025. Therefore GuruFocus does not calculate PS Ratio at this moment.

The historical rank and industry rank for Edding Genor Group Holdings's PS Ratio or its related term are showing as below:

HKSE:06998' s PS Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 1.04
Current: 1.04

During the past 2 years, Edding Genor Group Holdings's highest PS Ratio was 1.04. The lowest was 0.00. And the median was 0.00.

HKSE:06998's PS Ratio is ranked better than
75.32% of 952 companies
in the Drug Manufacturers industry
Industry Median: 2.345 vs HKSE:06998: 1.04

Edding Genor Group Holdings's Revenue per Sharefor the six months ended in Dec. 2025 was HK$1.62.

During the past 12 months, the average Revenue per Share Growth Rate of Edding Genor Group Holdings was 19.70% per year.

Back to Basics: PS Ratio


Edding Genor Group Holdings  (HKSE:06998) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Edding Genor Group Holdings PS Ratio Related Terms


Edding Genor Group Holdings PS Ratio Historical Data

* Premium members only.

The historical data trend for Edding Genor Group Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edding Genor Group Holdings PS Ratio Chart

Edding Genor Group Holdings Annual Data
Trend Dec24 Dec25
PS Ratio
0.00 0.00

Edding Genor Group Holdings Semi-Annual Data
Dec24 Dec25
PS Ratio 0.00 0.00

HKSE:06998 vs ZTS: PS Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Edding Genor Group Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edding Genor Group Holdings PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Edding Genor Group Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Edding Genor Group Holdings's PS Ratio falls into.


HKSE:06998
15GF Score
Edding Genor Group Holdings Ltd HKSE:06998
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edding Genor Group Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Edding Genor Group Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.69/
=

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Edding Genor Group Holdings Business Description

Address No. 36 Doukou Road, Room 406, Building 1, Hengqin New Area, Guangdong Province, Zhuhai, CHN
Edding Genor Group Holdings Ltd is an integrated specialty biopharmaceutical company, focusing on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. Through the acquisition of branded drug assets from multinational pharmaceutical companies (MNCs) and licensing in development and commercialisation rights of patented drugs from international biopharmaceutical companies, it has established a portfolio of originator-branded and other drugs. The company has two reportable operating segments: Manufacturing and Distribution, which generates the maximum revenue, and Research and development. Geographically, it derives maximum revenue from the Chinese mainland, and the rest from the USA and other markets.
15GF Score

Get the complete analysis for HKSE:06998

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.69
Price